Sides Bicker Over Bifurcation In Mirapex Case

Law360, New York (July 14, 2008, 12:00 AM EDT) -- Pfizer and the other defendants in the Mirapex case are pushing for the litigation to be broken up so that the jury is not swayed by financial considerations when determining liability over the drug that allegedly triggers a compulsive urge to gamble.

On Friday, the defendants pleaded with the court to split up the case, arguing that the liability phase should be separated from the damages phase.

“Here, bifurcation is warranted because evidence of defendants' finances is irrelevant to the issue of liability and its introduction...
To view the full article, register now.